Inflammatory and oxidative stress markers after intravenous insulin in percutaneous coronary intervention with stent in type 2 diabetes mellitus: a randomized controlled trial.
暂无分享,去创建一个
C. Polanczyk | B. Schaan | M. S. Benfato | F. S. Hackenhaar | C. Klein | M. Wainstein | P. Ledur | Simone de Souza Fantin | C. Lazzari
[1] C. Polanczyk,et al. Interleukin-18: an independent predictor of cardiovascular events in patients with acute coronary syndrome after 6 months of follow-up , 2009, Coronary Artery Disease.
[2] Richard Hellman,et al. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. , 2009, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[3] N. Sattar,et al. Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials , 2009, The Lancet.
[4] A. Kitabchi,et al. Proinflammatory cytokines in response to insulin-induced hypoglycemic stress in healthy subjects. , 2009, Metabolism: clinical and experimental.
[5] P. Cryer,et al. Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline. , 2009, The Journal of clinical endocrinology and metabolism.
[6] A. Gottsäter,et al. Renal angioplasty causes a rapid transient increase in inflammatory biomarkers, but reduced levels of interleukin-6 and endothelin-1 1 month after intervention , 2007, Journal of hypertension.
[7] A. Pavie,et al. Strict glycemic control reduces EuroSCORE expected mortality in diabetic patients undergoing myocardial revascularization. , 2007, The Journal of thoracic and cardiovascular surgery.
[8] V. Vainionpää,et al. Anti‐inflammatory effect of high‐dose insulin treatment after urgent coronary revascularization surgery , 2006, Acta anaesthesiologica Scandinavica.
[9] T. Rabelink,et al. Short-Term Pioglitazone Treatment Improves Vascular Function Irrespective of Metabolic Changes in Patients With Type 2 Diabetes , 2005, Journal of cardiovascular pharmacology.
[10] E. de Jonge,et al. Glucose, insulin and potassium applied as perioperative hyperinsulinaemic normoglycaemic clamp: effects on inflammatory response during coronary artery surgery. , 2005, British journal of anaesthesia.
[11] F. Santilli,et al. Enhanced soluble CD40 ligand contributes to endothelial cell dysfunction in vitro and monocyte activation in patients with diabetes mellitus: effect of improved metabolic control , 2005, Diabetologia.
[12] J Herlitz,et al. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. , 2005, European heart journal.
[13] Jian‐Jun Li,et al. Increased C-Reactive Protein Level After Renal Stent Implantation in Patients with Atherosclerotic Renal Stenosis , 2004, Angiology.
[14] G. Kaur,et al. Impact of hypoglycemia and diabetes on CNS: Correlation of mitochondrial oxidative stress with DNA damage , 2004, Molecular and Cellular Biochemistry.
[15] Michael F. Wilson,et al. Anti-Inflammatory and Profibrinolytic Effect of Insulin in Acute ST-Segment–Elevation Myocardial Infarction , 2004, Circulation.
[16] James D Dziura,et al. Implementation of a safe and effective insulin infusion protocol in a medical intensive care unit. , 2004, Diabetes care.
[17] W. O’Neill,et al. Optimal glycemic control is associated with a lower rate of target vessel revascularization in treated type II diabetic patients undergoing elective percutaneous coronary intervention. , 2004, Journal of the American College of Cardiology.
[18] J. Ribeiro,et al. Plasma endothelin-1 levels after coronary stenting in humans. , 2003, The American journal of cardiology.
[19] G. Grunkemeier,et al. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. , 2003, The Journal of thoracic and cardiovascular surgery.
[20] G. Van den Berghe,et al. Intensive insulin therapy exerts antiinflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lectin levels. , 2003, The Journal of clinical endocrinology and metabolism.
[21] M. Cakir,et al. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. , 2003, The Journal of clinical endocrinology and metabolism.
[22] R. Marfella,et al. Inflammatory Cytokine Concentrations Are Acutely Increased by Hyperglycemia in Humans: Role of Oxidative Stress , 2002, Circulation.
[23] A. Aljada,et al. The anti-inflammatory and potential anti-atherogenic effect of insulin: a new paradigm , 2002, Diabetologia.
[24] G. V. Berghe,et al. Intensive insulin therapy in critically ill patients. , 2001, The New England journal of medicine.
[25] P. Pagel,et al. Hyperglycemia reduces coronary collateral blood flow through a nitric oxide-mediated mechanism. , 2001, American journal of physiology. Heart and circulatory physiology.
[26] R. Gibbons,et al. ACC/AHA Guidelines for Percutaneous Coronary Intervention (Revision of the 1993 PTCA Guidelines)—Executive Summary , 2001 .
[27] A. M. Lefer,et al. Elevated ambient glucose induces acute inflammatory events in the microvasculature: effects of insulin. , 2001, American journal of physiology. Endocrinology and metabolism.
[28] W. Zhu,et al. Insulin Prevents Cardiomyocytes From Oxidative Stress–Induced Apoptosis Through Activation of PI3 Kinase/ Akt , 2000, Circulation.
[29] A. Aljada,et al. Insulin inhibits the expression of intercellular adhesion molecule-1 by human aortic endothelial cells through stimulation of nitric oxide. , 2000, The Journal of clinical endocrinology and metabolism.
[30] R. Natarajan,et al. Molecular Mechanisms of Tumor Necrosis Factor α Gene Expression in Monocytic Cells via Hyperglycemia-induced Oxidant Stress-dependent and -independent Pathways* , 2000, The Journal of Biological Chemistry.
[31] G. Paolisso,et al. Hemodynamic effects of acute hyperglycemia in type 2 diabetic patients. , 2000, Diabetes care.
[32] Sachiko Hattori,et al. High-glucose-induced nuclear factor κB activation in vascular smooth muscle cells , 2000 .
[33] A. Aljada,et al. Effect of insulin on human aortic endothelial nitric oxide synthase. , 2000, Metabolism: clinical and experimental.
[34] M. Hadamitzky,et al. Diabetes mellitus and the clinical and angiographic outcome after coronary stent placement. , 1998, Journal of the American College of Cardiology.
[35] F. Numano,et al. Glucose-Dependent Interleukin 6 and Tumor Necrosis Factor Production by Human Peripheral Blood Monocytes In Vitro , 1996, Diabetes.
[36] M. M. Bradford. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.
[37] B. Bistrian,et al. Intensive insulin therapy in critically ill patients. , 2002, The New England journal of medicine.
[38] E. Stadtman,et al. Determination of carbonyl content in oxidatively modified proteins. , 1990, Methods in enzymology.